A major Lancet review concludes taking paracetamol during pregnancy does not increase the risk of autism in children. This large-scale analysis of existing research provides the strongest evidence yet, supporting the long-standing advice from health authorities that the painkiller is safe for use.

The study arrives amid renewed public debate, following comments from former President Donald Trump linking the drug to developmental disorders. Researchers aimed to address these concerns with robust data, analyzing multiple cohort studies to provide clarity for expectant parents and healthcare providers navigating medication choices.

Medical groups have consistently endorsed paracetamol as the preferred pain reliever for pregnant women. This Lancet analysis reinforces that guidance, offering reassurance that its use for fever or pain management is not linked to autism. The findings should help dispel misinformation and guide clinical decisions.

Next, the focus will be on communicating these results clearly to the public. Healthcare professionals can now point to this comprehensive review when advising patients. The goal is to ensure women receive accurate information to make informed choices without unnecessary fear about standard medical treatments.